AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35128890 — intervention group
Group type: EXPERIMENTAL
Intervention: Training on T. solium taeniasis and cysticercosis control knowledge (once a year from 2016 to 2020)
Number of subjects: 663
Study 35128890 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 663
Study 35128890 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline awareness rate of T. solium taeniasis and cysticercosis control knowledge in intervention group
Number of subjects: 663
Study 35128890 — intervention group
Group type: COMPARATOR
Intervention: Baseline awareness rate of T. solium taeniasis and cysticercosis control knowledge in control group
Number of subjects: 663
Study 35128890 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of awareness rates based on education levels
Number of subjects: 663
Study 35128890 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of awareness rates based on duration of working experiences
Number of subjects: 663
Study 35128890 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of awareness rates among medical professionals with different education levels in intervention group
Number of subjects: 663
Study 33293312 — intervention group
Group type: EXPERIMENTAL
Intervention: OPASS programme
Number of subjects: 210
Study 33293312 — intervention group
Group type: COMPARATOR
Intervention: Attention control group
Number of subjects: 210
Study 36364919 — intervention group
Group type: EXPERIMENTAL
Intervention: LabinicTM (multi-strain probiotic)
Number of subjects: 0
Study 36364919 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32458282 — intervention group
Group type: EXPERIMENTAL
Intervention: TBR NFT (Theta/Beta Ratio Neurofeedback Training)
Number of subjects: 12
Study 32458282 — intervention group
Group type: COMPARATOR
Intervention: Sham NFT
Number of subjects: 12
Study 35259027 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver-reported PedsQL score
Number of subjects: 309
Study 35259027 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-reported PedsQL score
Number of subjects: 309
Study 35259027 — intervention group
Group type: EXPERIMENTAL
Intervention: Agreement between caregiver and child total PedsQL scores
Number of subjects: 309
Study 35259027 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with differences between caregiver and child report
Number of subjects: 309
Study 33677624 — intervention group
Group type: EXPERIMENTAL
Intervention: Transection of POL
Number of subjects: 8
Study 33677624 — intervention group
Group type: EXPERIMENTAL
Intervention: Transection of dMCL
Number of subjects: 8
Study 33677624 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined torque contributions of dMCL and POL
Number of subjects: 8
Study 33677624 — intervention group
Group type: COMPARATOR
Intervention: Intact state
Number of subjects: 8
Study 33071986 — intervention group
Group type: EXPERIMENTAL
Intervention: Gushen'antai pills (GSATP) 6 g, tid for 12 weeks
Number of subjects: 271
Study 33071986 — intervention group
Group type: EXPERIMENTAL
Intervention: Gushen'antai pills (GSATP) 6 g, tid for 12 weeks (younger than 35 years)
Number of subjects: 271
Study 35789604 — intervention group
Group type: EXPERIMENTAL
Intervention: Sanfeng Tongqiao Diwan
Number of subjects: 0
Study 35789604 — intervention group
Group type: COMPARATOR
Intervention: Tongqiao Biyan Pian
Number of subjects: 0
Study 32667155 — intervention group
Group type: EXPERIMENTAL
Intervention: Muscular tissue oxygen saturation‐guided care (n = 400)
Number of subjects: 800
Study 32667155 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n = 399)
Number of subjects: 800
Study 34590286 — intervention group
Group type: EXPERIMENTAL
Intervention: Unsupervised statistical monitoring using mixed‐effects statistical models
Number of subjects: 0
Study 33081983 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized nutritional support to reach caloric and protein goals
Number of subjects: 378
Study 33081983 — intervention group
Group type: COMPARATOR
Intervention: Standard hospital food
Number of subjects: 378
Study 32227755 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial invasive strategy (angiography and revascularization when feasible) plus medical therapy
Number of subjects: 5179
Study 32227755 — intervention group
Group type: COMPARATOR
Intervention: Initial conservative strategy (medical therapy alone and angiography if medical therapy failed)
Number of subjects: 5179
Study 32227755 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial invasive strategy
Number of subjects: 5179
Study 32227755 — intervention group
Group type: COMPARATOR
Intervention: Initial conservative strategy
Number of subjects: 5179
Study 32227755 — intervention group
Group type: EXPERIMENTAL
Intervention: Key secondary outcome
Number of subjects: 5179
Study 35945651 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 raw eggs (∼30 g protein)
Number of subjects: 45
Study 35945651 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 boiled eggs (∼30 g protein)
Number of subjects: 45
Study 35945651 — intervention group
Group type: COMPARATOR
Intervention: Control breakfast (∼5 g protein)
Number of subjects: 45
Study 33962515 — intervention group
Group type: EXPERIMENTAL
Intervention: Education plus therapeutic alliance
Number of subjects: 222
Study 33962515 — intervention group
Group type: EXPERIMENTAL
Intervention: Education only
Number of subjects: 222
Study 33962515 — intervention group
Group type: COMPARATOR
Intervention: No education
Number of subjects: 222
Study 32560714 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component intervention including workstation ergonomics, health promotion information group workshops, neck exercises, and an adherence app for 12 weeks.
Number of subjects: 120
Study 32560714 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component intervention
Number of subjects: 120
Study 32560714 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 120
Study 32843262 — intervention group
Group type: EXPERIMENTAL
Intervention: Empowerment-based intervention
Number of subjects: 85
Study 35288105 — intervention group
Group type: EXPERIMENTAL
Intervention: Diamondback 360 Coronary Orbital Atherectomy System
Number of subjects: 2000
Study 35288105 — intervention group
Group type: COMPARATOR
Intervention: Conventional balloon angioplasty
Number of subjects: 2000
Study 36257950 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 181
Study 36257950 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care (SoC)
Number of subjects: 181
Study 33626028 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative hypotension (POH) defined as a single MAP measurement below thresholds of ≤75, ≤65, and ≤55 mm Hg.
Number of subjects: 67968
Study 33626028 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative hypotension (POH) with intraoperative hypotension (IOH) defined as intraoperative MAP ≤65 mm Hg.
Number of subjects: 67968
Study 33626028 — intervention group
Group type: COMPARATOR
Intervention: Postoperative hypotension (POH) without intraoperative hypotension (IOH).
Number of subjects: 67968
Study 35126939 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrapulse CO2 lattice laser combined with PRP and Yifu
Number of subjects: 700
Study 35126939 — intervention group
Group type: COMPARATOR
Intervention: Ultrapulse CO2 lattice laser
Number of subjects: 700
Study 34959931 — intervention group
Group type: EXPERIMENTAL
Intervention: High Protein Diet (HP)
Number of subjects: 20
Study 34959931 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean Diet (M)
Number of subjects: 20
Study 34342814 — intervention group
Group type: EXPERIMENTAL
Intervention: Business letter invitation (n=360)
Number of subjects: 708
Study 34342814 — intervention group
Group type: COMPARATOR
Intervention: Greeting card invitation (n=348)
Number of subjects: 708
Study 33450071 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline dual‐energy X‐ray absorptiometry (DXA) appendicular lean mass (ALM) adjusted for height2
Number of subjects: 11187
Study 33901511 — intervention group
Group type: EXPERIMENTAL
Intervention: Pursuit eye movements immediately after fear memory reactivation
Number of subjects: 38
Study 33901511 — intervention group
Group type: EXPERIMENTAL
Intervention: Pursuit eye movements 10 min after fear memory reactivation
Number of subjects: 38
Study 34262052 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedle patches (MNPs)
Number of subjects: 22
Study 34262052 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular (IM) route
Number of subjects: 22
Study 36138087 — intervention group
Group type: EXPERIMENTAL
Intervention: Icodextrin (ICO)
Number of subjects: 22
Study 36138087 — intervention group
Group type: COMPARATOR
Intervention: Glucose (GLU)
Number of subjects: 22
Study 34616361 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg imigliptin
Number of subjects: 37
Study 34616361 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg imigliptin
Number of subjects: 37
Study 34616361 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg alogliptin
Number of subjects: 37
Study 34616361 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 32160268 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine ingestion
Number of subjects: 0
Study 32160268 — intervention group
Group type: COMPARATOR
Intervention: Placebo ingestion
Number of subjects: 0
Study 36372282 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy massage (oil blend), applied once a day for 15 minutes over 3 weeks
Number of subjects: 48
Study 36372282 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 48
Study 33449819 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized feedback intervention over four weeks for least regular sleepers (N = 22, SRI ≤ 81.4)
Number of subjects: 45
Study 33449819 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in CATS Time during the intervention
Number of subjects: 45
Study 33449819 — intervention group
Group type: EXPERIMENTAL
Intervention: CATS Benefits
Number of subjects: 45
Study 33499438 — intervention group
Group type: EXPERIMENTAL
Intervention: cd‐HA‐gelatin (medium or low molecular weight)
Number of subjects: 48
Study 33499438 — intervention group
Group type: EXPERIMENTAL
Intervention: cd‐HA‐gelatin (high molecular weight)
Number of subjects: 48
Study 33499438 — intervention group
Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 48
Study 35219277 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarilumab 400 mg
Number of subjects: 1822
Study 35219277 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1822
Study 35219277 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarilumab
Number of subjects: 1822
Study 33287626 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted levels of very small and small very low-density lipoprotein, intermediate-density lipoprotein, and large low-density lipoprotein
Number of subjects: 3279
Study 33287626 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted diastolic blood pressure
Number of subjects: 3279
Study 33287626 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically predicted systolic blood pressure
Number of subjects: 3279
Study 34632933 — intervention group
Group type: EXPERIMENTAL
Intervention: 120 mg/day standardized cranberry extract
Number of subjects: 64
Study 34632933 — intervention group
Group type: EXPERIMENTAL
Intervention: 240 mg/day standardized cranberry extract
Number of subjects: 64
Study 34632933 — intervention group
Group type: COMPARATOR
Intervention: Standard management (SM)
Number of subjects: 64
Study 34632933 — intervention group
Group type: COMPARATOR
Intervention: Nitrofurantoin administration
Number of subjects: 64
Study 34632933 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized cranberry extract
Number of subjects: 64
Study 33987685 — intervention group
Group type: EXPERIMENTAL
Intervention: European Childhood Obesity Risk Evaluation (CORE) index
Number of subjects: 2775
Study 32986391 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric drop jump training (PJT-early)
Number of subjects: 76
Study 32986391 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric drop jump training (PJT-late)
Number of subjects: 76
Study 32986391 — intervention group
Group type: COMPARATOR
Intervention: Active soccer-control group (CG-early)
Number of subjects: 76
Study 32986391 — intervention group
Group type: COMPARATOR
Intervention: Active soccer-control group (CG-late)
Number of subjects: 76
Study 35990584 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP delivery integrated into ART clinics
Number of subjects: 1381
Study 35990584 — intervention group
Group type: COMPARATOR
Intervention: ART for partners living with HIV
Number of subjects: 1381
Study 35990584 — intervention group
Group type: EXPERIMENTAL
Intervention: ART for partners living with HIV after PrEP launch
Number of subjects: 1381
Study 35990584 — intervention group
Group type: COMPARATOR
Intervention: ART for partners living with HIV before PrEP launch
Number of subjects: 1381
Study 34907082 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipatasertib plus Paclitaxel
Number of subjects: 151
Study 34907082 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus Paclitaxel
Number of subjects: 151
Study 34907082 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipatasertib treatment
Number of subjects: 151
Study 34907082 — intervention group
Group type: EXPERIMENTAL
Intervention: High baseline pAKT levels
Number of subjects: 151
Study 32464485 — intervention group
Group type: EXPERIMENTAL
Intervention: Mock interviews with trained actors as a training tool for child interviewing
Number of subjects: 35
Study 35133064 — intervention group
Group type: COMPARATOR
Intervention: Imatinib mesylate 0.1% (single dose)
Number of subjects: 16
Study 35133064 — intervention group
Group type: COMPARATOR
Intervention: Imatinib mesylate 0.1% (multiple doses, once daily for 7 days)
Number of subjects: 16
Study 35133064 — intervention group
Group type: COMPARATOR
Intervention: Imatinib mesylate 0.3% (single dose)
Number of subjects: 16
Study 35133064 — intervention group
Group type: COMPARATOR
Intervention: Imatinib mesylate 0.3% (multiple doses, once daily for 7 days)
Number of subjects: 16
Study 35133064 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo (single dose)
Number of subjects: 16
Study 35133064 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo (multiple doses, once daily for 7 days)
Number of subjects: 16
Study 34180949 — intervention group
Group type: EXPERIMENTAL
Intervention: Home health postoperative DBS management
Number of subjects: 44
Study 34180949 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 44
Study 35184004 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol liking
Number of subjects: 294
Study 35184004 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater alcohol liking and wanting
Number of subjects: 294
Study 35184004 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater alcohol sedation
Number of subjects: 294
Study 33222455 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral immunonutrition (EIN)
Number of subjects: 120
Study 33222455 — intervention group
Group type: COMPARATOR
Intervention: Enteral nutrition (EN)
Number of subjects: 120
Study 33222455 — intervention group
Group type: COMPARATOR
Intervention: Enteral immunonutrition (EIN) and Enteral nutrition (EN)
Number of subjects: 120
Study 616497045 — intervention group
Group type: EXPERIMENTAL
Intervention: Eggshell calcium (300 mg/d)
Number of subjects: 54
Study 616497045 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium carbonate (300 mg/d)
Number of subjects: 54
Study 616497045 — intervention group
Group type: COMPARATOR
Intervention: Placebo (no calcium supplementation)
Number of subjects: 54
Study 35115339 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol 200 µg
Number of subjects: 39
Study 35115339 — intervention group
Group type: COMPARATOR
Intervention: Budesonide/formoterol 200/6 µg
Number of subjects: 39
Study 35115339 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol
Number of subjects: 39
Study 33657675 — intervention group
Group type: EXPERIMENTAL
Intervention: Alteplase
Number of subjects: 503
Study 33657675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 503
Study 33724254 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline (100 mg/day) plus pentoxifylline (400 mg three times daily)
Number of subjects: 56
Study 33724254 — intervention group
Group type: COMPARATOR
Intervention: Sertraline (100 mg/day) plus placebo
Number of subjects: 56
Study 32909815 — intervention group
Group type: EXPERIMENTAL
Intervention: D-NAM appliance
Number of subjects: 34
Study 32909815 — intervention group
Group type: COMPARATOR
Intervention: No-treatment (control)
Number of subjects: 34
Study 35834107 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes-specific nutritional supplement (DSNS) plus standard of care (SOC)
Number of subjects: 171
Study 35834107 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) alone
Number of subjects: 171
Study 34629370 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate job strain
Number of subjects: 158
Study 34629370 — intervention group
Group type: EXPERIMENTAL
Intervention: High job strain
Number of subjects: 158
Study 34629370 — intervention group
Group type: EXPERIMENTAL
Intervention: Effort-reward imbalance
Number of subjects: 158
Study 34629370 — intervention group
Group type: EXPERIMENTAL
Intervention: High overcommitment
Number of subjects: 158
Study 34629370 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate exposure to musculoskeletal pain/injury
Number of subjects: 158
Study 34629370 — intervention group
Group type: EXPERIMENTAL
Intervention: High exposure to musculoskeletal pain/injury
Number of subjects: 158
Study 34629370 — intervention group
Group type: EXPERIMENTAL
Intervention: Degree level education
Number of subjects: 158
Study 34629370 — intervention group
Group type: EXPERIMENTAL
Intervention: Elementary/high school level education
Number of subjects: 158
Study 34629370 — intervention group
Group type: EXPERIMENTAL
Intervention: Low physical activity
Number of subjects: 158
Study 34629370 — intervention group
Group type: EXPERIMENTAL
Intervention: Age 31-40 years
Number of subjects: 158
Study 34629370 — intervention group
Group type: EXPERIMENTAL
Intervention: Age ≥41 years
Number of subjects: 158
Study 34629370 — intervention group
Group type: EXPERIMENTAL
Intervention: Insomnia symptoms
Number of subjects: 158
Study 34629370 — intervention group
Group type: EXPERIMENTAL
Intervention: Age >40 years
Number of subjects: 158
Study 33256753 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity coaching intervention (education session + five 20-min telephone sessions)
Number of subjects: 120
Study 33256753 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity coaching intervention
Number of subjects: 120
Study 33256753 — intervention group
Group type: COMPARATOR
Intervention: Control group (education session only)
Number of subjects: 120
Study 35736783 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication intervention (2.5-minute video, 3-page brief questionnaire, wallet card with question prompts)
Number of subjects: 53
Study 35736783 — intervention group
Group type: EXPERIMENTAL
Intervention: Communication intervention
Number of subjects: 53
Study 33671220 — intervention group
Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid (DHA) 75 mg/kg body weight daily for 14 days
Number of subjects: 225
Study 33671220 — intervention group
Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid (DHA)
Number of subjects: 225
Study 32370780 — intervention group
Group type: EXPERIMENTAL
Intervention: Preemptive local infiltration with betamethasone and ropivacaine
Number of subjects: 116
Study 32370780 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine alone
Number of subjects: 116
Study 34740596 — intervention group
Group type: EXPERIMENTAL
Intervention: COMPASS‐TC (comprehensive transitional care model)
Number of subjects: 2262
Study 34740596 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2262
Study 35293153 — intervention group
Group type: EXPERIMENTAL
Intervention: HFNCO (2 L/kg/min)
Number of subjects: 87
Study 33864153 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosfomycin-trometamol treatment for ASB (77 patients)
Number of subjects: 594
Study 33864153 — intervention group
Group type: COMPARATOR
Intervention: No intervention (75 patients)
Number of subjects: 594
Study 35695234 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized telephone coaching (average of 13 sessions, 48 minutes each over 6 months)
Number of subjects: 314
Study 35695234 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized telephone coaching
Number of subjects: 314
Study 35695234 — intervention group
Group type: COMPARATOR
Intervention: TAU+
Number of subjects: 314
Study 34384540 — intervention group
Group type: EXPERIMENTAL
Intervention: Vi‐tetanus toxoid conjugate vaccine (Vi‐TT)
Number of subjects: 41344
Study 34384540 — intervention group
Group type: COMPARATOR
Intervention: SA 14‐14‐2 Japanese encephalitis (JE) vaccine
Number of subjects: 41344
Study 32799667 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic headache diary (daily assessment of headache presence and severity)
Number of subjects: 182
Study 32799667 — intervention group
Group type: COMPARATOR
Intervention: Recall questionnaire (retrospective estimation of headache days on a monthly basis)
Number of subjects: 182
Study 32799667 — intervention group
Group type: EXPERIMENTAL
Intervention: Headaches lasting 8 hours or more
Number of subjects: 182
Study 32799667 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-to-severe headaches
Number of subjects: 182
Study 33927110 — intervention group
Group type: EXPERIMENTAL
Intervention: 100% O2 (hyperoxic setting [HS])
Number of subjects: 15
Study 33927110 — intervention group
Group type: COMPARATOR
Intervention: Hypoxic air (nonhyperoxic setting [NHS])
Number of subjects: 15
Study 33139234 — intervention group
Group type: EXPERIMENTAL
Intervention: Parker Flex-Tip tube (PFT)
Number of subjects: 40
Study 33139234 — intervention group
Group type: COMPARATOR
Intervention: Standard Portex tube (PTT)
Number of subjects: 40
Study 35440935 — intervention group
Group type: EXPERIMENTAL
Intervention: Coriander seed oil (CSO) 200 mg daily for 28 days
Number of subjects: 0
Study 32341106 — intervention group
Group type: EXPERIMENTAL
Intervention: PDE4 inhibition
Number of subjects: 0
Study 32341106 — intervention group
Group type: COMPARATOR
Intervention: Control not specified
Number of subjects: 0
Study 33423550 — intervention group
Group type: EXPERIMENTAL
Intervention: Momelotinib (MMB)
Number of subjects: 820
Study 33423550 — intervention group
Group type: COMPARATOR
Intervention: Danazol
Number of subjects: 820